SXTP
60 DEGREES PHARMACEUTICALS, INC.
Key Financials
Net Income
$-7365158
↑ 7.3%
Operating Income
$-7758579
↑ 20.1%
Revenue
$1.0M
↑ 65.5%
Gross Profit
$223776
↑ 0.4%
Total Assets
$5.4M
↓ 6.8%
EPS (Diluted)
$-11.73
↑ 36.8%
Total Liabilities
$2.0M
↑ 10.1%
Cash & Equivalents
$1.5M
↓ 9.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 3 | 5/19/2026 | View on SEC |
| 8-K | 5/18/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/13/2026 | View on SEC |
| 10-K | 3/30/2026 | View on SEC |
| 8-K | 3/20/2026 | View on SEC |
| 424B5 | 3/13/2026 | View on SEC |
| 8-K | 3/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SXTP |
| Company Name | 60 DEGREES PHARMACEUTICALS, INC. |
| CIK | 1946563 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 202-327-5422 |